PITTSBURGH (AP) — PITTSBURGH (AP) — NeuBase Therapeutics, Inc. (NBSE) on Tuesday reported a loss of $4.4 million in its fiscal first quarter.The Pittsburgh-based company said it had a loss of 13 cents per share._____This story was generated by  Automated Insights  (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a  Zacks stock report on NBSE  at https://www.zacks.com/ap/NBSE